HIV AND DEPRESSION
The severity of depressive symptoms has repeatedly been associated with the presence of self-reported cognitive difficulties in people with HIV, even in the absence of impairment on neuropsychological testing. It is unclear if treatment of depressive symptoms will lead to improvements in cognition.
Good Days Ahead (GDA) is an interactive Computerized Cognitive-Behavioral Therapy (cCBT) program developed to address symptoms of depression and anxiety. It has been found to be as effective as face-to-face CBT in decreasing symptoms of depression.
The goal of this project is to determine the extent to which decreased in depressive symptoms as a result of treatment with the Good Days Ahead program will result in changes in cognition in individuals living with HIV.